Product Information
BORTEZOMIB 3.5 MG VIAL is a generic product labeled by Camber Pharmaceuticals Inc., priced at $43.3460 per EA under NDC 31722030331. Its NADAC has been published 4 times since Mar 26, 2025.
Strength
3.5 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722030331
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
3/26/2025
Active Ingredients
BORTEZOMIBApproval Type
Generic (ANDA)
FDA Application
ANDA212204On Market Since
5/3/2024
Pharmacological Classes
Price Statistics
The NADAC for BORTEZOMIB 3.5 MG VIAL has been published 4 times since Mar 26, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $43.3460 per EA |
|---|---|
| All-time high | $43.3460 (Apr 16, 2025) |
| All-time low | $43.3460 (Mar 26, 2025) |
| Median price | $43.3460 |
| Average price | $43.3460 |
| Largest weekly change | 0.0% (Apr 2, 2025) |
| Weeks tracked | 4 |
| Tracking since | Mar 26, 2025 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BORTEZOMIB 3.5 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BORTEZOMIB 3.5 MG VIAL, manufactured by Camber Pharmaceuticals Inc., is $43.3460 per EA (NDC 31722030331), effective Apr 16, 2025.
How has the price of BORTEZOMIB 3.5 MG VIAL changed over time?
Over the history we have for it, the NADAC for BORTEZOMIB 3.5 MG VIAL has held within roughly two percent of its current level. It has been tracked across 4 weekly CMS publications since Mar 26, 2025.
What are the highest and lowest recorded NADAC prices for BORTEZOMIB 3.5 MG VIAL?
Since Mar 26, 2025, the NADAC for BORTEZOMIB 3.5 MG VIAL has ranged from a low of $43.3460 (Mar 26, 2025) to a high of $43.3460 (Apr 16, 2025), with a median of $43.3460 per EA.
Are there cheaper alternatives to BORTEZOMIB 3.5 MG VIAL?
8 NADAC-published products share the same active ingredient, strength, and dosage form as BORTEZOMIB 3.5 MG VIAL, but none are currently priced below it.
Who manufactures BORTEZOMIB 3.5 MG VIAL?
BORTEZOMIB 3.5 MG VIAL (NDC 31722030331) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification